Evaluation and Characteristics of a New Direct Compression Performance Excipient - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Evaluation and Characteristics of a New Direct Compression Performance Excipient
The authors investigated the tableting properties of PanExcea MHC300G, a high-performance excipient.


Pharmaceutical Technology
Volume 35, Issue 3

References

1. D. McCormik, Pharm. Technol. 5, (4) 52–62 (2005) .

2. N.A. Armstrong, Encyclopedia of Pharmaceutical Technology, Informa Healthcare USA, Inc. (New York, Third Edition, 2006).

3. H.G. Kristensen and T. Schaefer, Drug Dev. and Ind. Pharm. 13, 803–872 (1987).

4. A.J. Hlinak, et al., J. of Pharm. Innov. 1, 12–17 (2006).

5. M. Jivraj, L.G. Martini, C.M. Thomson, Pharm. Sci. and Technol. Today, 3, 58–63 (2000).

6. R.J. Roberts, R.C. Rowe, Int. J. of Pharm. 36, 205–209 (1987).

7. K. van der Voort Maarschalk, G.K. Bolhuis, Pharm. Technol. 23, 34–46 (1999).

8. K. van der Voort Maarschalk et al., Int. J. of Pharm. 151, 27–34 (1997).

9. G.K. Bolhuis, N.A. Armstrong, Pharm. Dev. and Technol. 11, 111–124 (2006).

10. G. Bubb, Tablets and Capsules, 7, (2007).

11. IPEC–Americas, Frequently Asked Questions web page, http://ipecamericas.org/about/faqs/, accessed Feb. 16, 2011.

12. N. Deorkar, Tablets and Capsules, 8, 22–26 (2008).

13. L. Mīinea, J. Farina, M. Kallam, N. Deorkar, Pharm. Processing, Feb. 2009, http://www.pharmpro.com/Articles/2009/03/A-New-World-of-Excipients-for-Oral-Solid-Dosage-Formulation/, accessed Feb. 16, 2011.

14. S.K. Nachaegari, A.K. Bansal, Pharm. Technol. 28 (1) 52–64 (2004).

15. M.C. Gohel, P.D. Jogani, J. of Pharm. and Pharm. Sci. 8, 76–93 (2005).

16. C. Moreton, "Functionality and Performance of Excipients in a Quality-by-Design World: Parts 1–6," a series of papers published in each issue of vol. 12 of American Pharmaceutical Review (2009).

17. N. Deorkar, J. Farina, L. Mīinea, S. Randive, "Directly Compressible High Functionality Granular Microcrystalline Cellulose Based Excipient, Manufacturing Process and Use Thereof" PCT/US2008/011555 (Oct. 2008).

18. Mallinckrodt Baker, product profile for PanExcea MHC300G, http://www.mallbaker.com/Literature/Documents/PanExcea%20IR%20Product%20Profile%20Lit7001.pdf, accessed Feb. 16, 2011.

19. L. Mīinea, R. Mehta, J. Farina, N. Deorkar, "Granular Excipients Based on Microcrystalline Cellulose: DOE study of a lab-based scale high shear granulation process," poster presentation at "Excipient Fest Americas", (Puerto Rico, April 2008).

20. USP 34–NF 29 General Chapter <1174> "Powder Flow."

21. Carr, R. L. Chem. Eng. 72,163–168, 1965.

22. Hosokawa Micron, product profile for Hosokawa Micron Powder Characteristics Tester PT-S, http://www.hosokawa.co.uk/powdtest.php, accessed Feb. 16, 2011.

23. S.I.F. Badawy, D.B. Gray, M.A. Hussain, Pharm. Res. 23, 634–640 (2006).

24. T. Suzuki et al., J. of Pharm. and Pharmacol. 53, 609–616 (2001).

25. C.K. Tye, C. Sun, G.E. Amidon, J. of Pharm. Sci. 94, 465–472 (2005).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Source: Pharmaceutical Technology,
Click here